Shares of Hypermarcas (OTCMKTS:HYPMY - Get Free Report) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $4.72 and traded as low as $4.46. Hypermarcas shares last traded at $4.84, with a volume of 4,135 shares trading hands.
Analyst Ratings Changes
Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th.
Read Our Latest Stock Report on Hypermarcas
Hypermarcas Trading Down 2.6%
The firm has a market capitalization of $2.80 billion, a PE ratio of 18.42 and a beta of 0.77. The firm's 50-day simple moving average is $4.75 and its 200-day simple moving average is $3.94. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63.
Hypermarcas Announces Dividend
The company also recently declared a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be given a dividend of $0.0345 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a dividend yield of 281.0%. Hypermarcas's dividend payout ratio (DPR) is 50.00%.
About Hypermarcas
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
